Esperion Therapeutics, Inc.: capex
| Value | {"amount": 6783, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | superseded |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/02b354c5-fdeb-4fad-96c8-96f683db795e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-14-002320Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/capex/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/02b354c5-fdeb-4fad-96c8-96f683db795e
History
- no predecessors — first report